TANIA FABIAN-NAVARRETE: Open Payments
NPI 1134850498 · WESLACO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$108 in 6 payments from 6 companies in 2025. Trend: 2023 $393 · 2024 $251 · 2025 $108
Food & beverage: $108
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 1 | $20 |
| Lilly USA, LLC | 1 | $20 |
| Phadia US Inc. | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| ABBVIE INC. | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: TRELEGY ELLIPTA, JARDIANCE, ImmunoCAP, Kerendia, UBRELVY, FARXIGA.
Industry payments across TX — which companies pay providers there.
